Companies /Healthcare

Cardiff Oncology Inc

NASDAQ: CRDF Biotechnology
$1.12
▼ $0.06 (−5.08%) today
Markets closed · 7:01pm ET

Fundamentals

Market Cap
$87.1M
Revenue (TTM)
$508,000
EPS (TTM)
$-0.57
52-Week Range
$1 – $3
Street Target
$5.81

About Cardiff Oncology

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. The company is headquartered in San Diego, California.

CRDF Coverage